<!DOCTYPE html>
<html>
  <!DOCTYPE html>
<html lang="en">
<head>
  <meta http-equiv="content-type" content="text/html; charset=utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
  
  <title>PDAC - Qian&#39;s blog</title>
  <link rel="icon" href="https://i.imgur.com/SrZt9VU.jpg" type="image/x-icon">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0">
  
  <meta name="keywords" content=scRNA,tumor>
  
  
  
    <link rel="alternate" href="/atom.xml " title="Qian&#39;s blog" type="application/atom+xml">
  

  
<link rel="stylesheet" href="/css/style.css">

<meta name="generator" content="Hexo 6.3.0"></head>

  <body>
    <div class="container">
      <header class="header">
  <div class="blog-title">
    <a href="/" class="logo">Qian&#39;s blog</a>
    <div class="subtitle"></div>
  </div>
  <nav class="navbar">
    <ul class="menu">
      
        <li class="menu-item">
          <a href="/" class="menu-item-link">Home</a>
        </li>
      
        <li class="menu-item">
          <a href="/CV" class="menu-item-link">CV</a>
        </li>
      
        <li class="menu-item">
          <a href="/atom.xml" class="menu-item-link">RSS</a>
        </li>
      
    </ul>
  </nav>
</header>

<article class="post">
  <div class="post-title">
    <h1 class="article-title">PDAC</h1>
  </div>

  <!-- 文章目录 -->
  

  <div class="post-content">
    <p>Recently, I read a new paper about <a
target="_blank" rel="noopener" href="https://www.nature.com/articles/s41467-023-36296-4?utm_source=pocket_saves">pancreatic
ductal adenocarcinoma</a> (PDAC), published in <em>nature
communication</em>.</p>
<p>It mainly studies human PDAC and applies scRNA sequencing on freshly
collected human PDAC samples before or after chemotherapy. The abstract
has three main results: 1) They find a heterogeneous mixture of basal
and classical cancer cell subtypes, along with distinct
cancer-associated fibroblast and macrophage subpopulations. 2) Classical
and basal-like cancer cells exhibit similar transcriptional responses to
chemotherapy and do not demonstrate a shift towards a basal-like
transcriptional program among treated samples. 3) Ligand-receptors
decrease interactions in treated samples, particularly between TIGIT on
CD8 + T cells and its receptor on cancer cells, and identify TIGIT as
the significant inhibitory checkpoint molecule of CD8 + T cells.</p>
<p>Let us see how they analyze the three results.</p>
<p>One、How to judge the cut-off between basal and classical cancer cell
subtypes?</p>
<p>Here, the researchers found there is no difference between upon
conditions.</p>
<p><img
src="https://raw.githubusercontent.com/yiranzhimo/Pictures/master/PDAC_1.png" /></p>
<p>All samples but one were comprised of a mixture of basal and
classical cancer cells in varying proportions.</p>
<blockquote>
<p>Although we did not observe this specific intermediate state gene
signature (the number of samples in each dataset may limit the
generalizability of such a signature), we did discover cancer cells in
numerous patient samples that expressed both basal and classical
histological markers to varying degrees.</p>
</blockquote>
<p>Two 、How to detect Classical and basal-like cancer cells exhibiting
similar transcriptional responses?</p>
<p><img
src="https://raw.githubusercontent.com/yiranzhimo/Pictures/master/PDAC_3.png" /></p>
<p>Through gene sets score, they found two groups' cells are mostly
overlapped.</p>
<p>Three、How to ensure ligand-receptors decreased interactions in
treated samples?</p>
<p><img
src="https://raw.githubusercontent.com/yiranzhimo/Pictures/master/PDAC_2.png" /></p>
<p>They employed CellPhoneDB to infer potential ligand-receptor
interactions (LRIs) between malignant epithelial cells, TAM and CAF
subpopulations, CD8 +and CD4 + T cells, MDSCs, and DCs in naïve and
treated samples and found a general decrease of cell-cell interactions
in the chemotherapy-treated group by fold change value.</p>

  </div>
  <div class="post-meta">
    <span class="post-time" style="color:#646060;font-size:13px">2023-02-15</span>
  </div>

  <div class="post-footer">
    
      <ul class="post-tag-list" itemprop="keywords"><li class="post-tag-list-item"><a class="post-tag-list-link" href="/tags/scRNA/" rel="tag">scRNA</a></li><li class="post-tag-list-item"><a class="post-tag-list-link" href="/tags/tumor/" rel="tag">tumor</a></li></ul>
    

    <a href="#top" class="top">Back to Top</a>
  </div>
</article>

<!-- 评论插件 -->

<footer>
  2023
  <span class="author">
    Qian Li
  </span>
</footer>


    </div>
  <script type="text/x-mathjax-config">
    MathJax.Hub.Config({
        tex2jax: {
            inlineMath: [ ["$","$"], ["\\(","\\)"] ],
            skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code'],
            processEscapes: true
        }
    });
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax();
        for (var i = 0; i < all.length; ++i)
            all[i].SourceElement().parentNode.className += ' has-jax';
    });
</script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML"></script>

</body>
</html>